Britain Approves Merck's Molnupiravir COVID-19 Pill

Translator

Tempo.co

Editor

Laila Afifa

4 November 2021 22:21 WIB

TEMPO.CO, JakartaBritain on Thursday, Nov. 4, became the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by U.S.-based Merck (MRK.N) and Ridgeback Biotherapeutics, in a boost to the fight against the pandemic.

Britain's Medicines and Healthcare products Regulatory Agency (MHRA) recommended the drug, molnupiravir, for use in people with mild to moderate COVID-19 and at least one risk factor for developing severe illness, such as obesity, older age diabetes, and heart disease.

It will be administered as soon as possible following a positive COVID-19 test and within five days of the onset of symptoms, the regulator said, citing clinical data. The green light is the first for an oral antiviral treatment for COVID-19 and the first for a COVID-19 drug that will be administered widely in the community.

Treatments to tackle the pandemic, which has killed more than 5.2 million people worldwide, have so far focused mainly on vaccines. Other options, including Gilead's (GILD.O) infused antiviral remdesivir and generic steroid dexamethasone, are generally only given after a patient has been hospitalised.

Merck's Molnupiravir has been closely watched since data last month showed it could halve the chances of dying or being hospitalised for those most at risk of developing severe COVID-19 when given early in the illness. 

Molnupiravir, which will be branded as Lagevrio in Britain, is designed to introduce errors into the genetic code of the coronavirus that causes COVID-19 and is taken twice a day for five days.

Professor Stephen Powis, national medical director for the National Health Service (NHS) in England, said the drug would be administered to patients at higher risk of complications as Britain heads into one of the most challenging winters ever.

A wider rollout will follow if it is clinically and cost effective in reducing hospitalisations and death, he added.
"We are now working across government and the NHS to urgently get this treatment to patients initially through a national study so we can collect more data on how antivirals work in a mostly vaccinated population," UK vaccines minister Maggie Throup told parliament.

Read: Merck Seeks First U.S. Authorization for COVID-19 Pill

REUTERS



101-year-old Chinese COVID-19 patient Cured after 5 Days in Hospital

20 jam lalu

101-year-old Chinese COVID-19 patient Cured after 5 Days in Hospital

A 101-year-old COVID-19 patient expresses her thanks to the medical staff who have cared for her over the previous five days.


Jokowi Wants Inflation Handled like COVID-19: Minister Tito

4 hari lalu

Jokowi Wants Inflation Handled like COVID-19: Minister Tito

Indonesia's Home Affairs Minister Tito Karnavian stated that he was asked by President Jokowi to handle inflation like handling COVID-19.


Malaysia Reports 2,421 New COVID-19 Infections, 9 New Deaths

6 hari lalu

Malaysia Reports 2,421 New COVID-19 Infections, 9 New Deaths

Malaysia reported 2,421 new COVID-19 infections, as of midnight Friday, bringing the national total to 4,996,964, according to the health ministry.


WHO: Drop in COVID-19 Alertness Could Create Deadly New Variant

6 hari lalu

WHO: Drop in COVID-19 Alertness Could Create Deadly New Variant

COVID-19 infections are at record highs in China and have started to rise in parts of Britain after months of decline.


Indonesia Switches Priority from COVID-19 Handling to Health Service Improvement

7 hari lalu

Indonesia Switches Priority from COVID-19 Handling to Health Service Improvement

Indonesian Health Minister states that the government's priority in the health sector has been shifted from COVID-19 handling to health services.


China to Loosen COVID Curbs after Massive Protests

8 hari lalu

China to Loosen COVID Curbs after Massive Protests

China is set to announce in the coming days an easing of its COVID-19 quarantine protocols.


China COVID-19 Lockdown; Protests Erupt in Xinjiang and Beijing after Deadly Fire

13 hari lalu

China COVID-19 Lockdown; Protests Erupt in Xinjiang and Beijing after Deadly Fire

Crowds took to the streets in Xinjiang's capital of Urumqi after a deadly fire triggered anger over their prolonged COVID-19 lockdown.


Jakarta's Daily COVID-19 Cases Surge to Over 1,000

14 hari lalu

Jakarta's Daily COVID-19 Cases Surge to Over 1,000

Jakarta's daily COVID-19 cases have soared in recent weeks. The hospital bed occupation rate (BOR), however, is still under control.


China's COVID-19 Infections Hit Record as Economic Outlook Darkens

14 hari lalu

China's COVID-19 Infections Hit Record as Economic Outlook Darkens

China reported record-high COVID-19 infections on Thursday with cities nationwide imposing localized lockdowns, mass testing, and other curbs.


Jakarta Starts Administering Second COVID-19 Booster for Elderly

16 hari lalu

Jakarta Starts Administering Second COVID-19 Booster for Elderly

The Jakarta government has started administering the second booster of COVID-19 shots for the elderly today, Nov. 23.